Successful management of severe infant bullous pemphigoid with omalizumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Successful management of severe infant bullous pemphigoid with omalizumab

Published:2012-03-02 Issue:5 Volume:166 Page:1140-1142
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:British Journal of Dermatology

Author:

Dufour C.¹,Souillet A.L.¹,Chaneliere C.¹,Jouen F.²,Bodemer C.³,Jullien D.⁴,Cambazard F.⁵,Joly P.²,Reix P.¹

Affiliation:

1. Service de Pédiatrie, Hospices Civils de Lyon, Lyon, France

2. Department of Dermatology, INSERM U 905, University of Rouen, Rouen, France

3. Service de Dermatologie, Hôpital Necker, Paris, France

4. Service de Dermatologie, Hospices Civils de Lyon, Lyon, France

5. Université de Saint‐Etienne, St Etienne, France

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2133.2011.10748.x

Reference10 articles.

1. Childhood Bullous Pemphigoid

2. Bullous Pemphigoid: Physiopathology, Clinical Features and Management

3. Bullous pemphigoid in a 4-month-old boy

4. Infantile bullous pemphigoid treated with intravenous immunoglobulin therapy

5. Severe Bullous Pemphigoid in an Infant- Successful Treatment with Rituximab

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Omalizumab and Dupilumab for the Treatment of Bullous Pemphigoid: A Systematic Review;Journal of Clinical Medicine;2024-08-16

2. Advancements in Bullous Pemphigoid Treatment: A Comprehensive Pipeline Update;American Journal of Clinical Dermatology;2023-12-29

3. Multiple blisters in a 6‐month old infant;Pediatric Dermatology;2023-10-23

4. The Eotaxin-1/CCR3 Axis and Matrix Metalloproteinase-9 Are Critical in Anti-NC16A IgE-Induced Bullous Pemphigoid;The Journal of Immunology;2023-09-06

5. Anti-interleukin 4 receptor α antibody for the treatment of Chinese bullous pemphigoid patients with diverse comorbidities and a 1-year follow-up: a monocentric real-world study;Frontiers in Immunology;2023-07-20

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3